Sam Chun Dang Pharm. Statistics

Total Valuation

Sam Chun Dang Pharm. has a market cap or net worth of KRW 2.66 trillion. The enterprise value is 2.66 trillion.

Market Cap	2.66T
Enterprise Value	2.66T

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Sam Chun Dang Pharm. has 23.26 million shares outstanding. The number of shares has increased by 3.20% in one year.

Current Share Class	n/a
Shares Outstanding	23.26M
Shares Change (YoY)	+3.20%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	6.98%
Owned by Institutions (%)	9.51%
Float	14.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.74
PB Ratio	9.61
P/TBV Ratio	n/a
P/FCF Ratio	99.25
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 157.80, with an EV/FCF ratio of 99.32.

EV / Earnings	-475.75
EV / Sales	13.02
EV / EBITDA	157.80
EV / EBIT	n/a
EV / FCF	99.32

Financial Position

The company has a current ratio of 3.31, with a Debt / Equity ratio of 0.15.

Current Ratio	3.31
Quick Ratio	2.76
Debt / Equity	0.15
Debt / EBITDA	3.20
Debt / FCF	2.02
Interest Coverage	6.37

Financial Efficiency

Return on equity (ROE) is 0.23% and return on invested capital (ROIC) is 1.37%.

Return on Equity (ROE)	0.23%
Return on Assets (ROA)	1.17%
Return on Capital (ROIC)	1.37%
Revenue Per Employee	510.70M
Profits Per Employee	-13.98M
Employee Count	400
Asset Turnover	0.46
Inventory Turnover	2.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +89.12% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+89.12%
50-Day Moving Average	135,280.00
200-Day Moving Average	125,630.00
Relative Strength Index (RSI)	36.91
Average Volume (20 Days)	373,179

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sam Chun Dang Pharm. had revenue of KRW 204.28 billion and -5.59 billion in losses. Loss per share was -245.53.

Revenue	204.28B
Gross Profit	98.88B
Operating Income	8.39B
Pretax Income	2.41B
Net Income	-5.59B
EBITDA	16.86B
EBIT	8.39B
Loss Per Share	-245.53

Full Income Statement

Balance Sheet

The company has 132.05 billion in cash and 54.01 billion in debt, giving a net cash position of 78.04 billion or 3,355.46 per share.

Cash & Cash Equivalents	132.05B
Total Debt	54.01B
Net Cash	78.04B
Net Cash Per Share	3,355.46
Equity (Book Value)	356.50B
Book Value Per Share	11,890.80
Working Capital	171.32B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 35.29 billion and capital expenditures -8.51 billion, giving a free cash flow of 26.78 billion.

Operating Cash Flow	35.29B
Capital Expenditures	-8.51B
Free Cash Flow	26.78B
FCF Per Share	1,151.65

Full Cash Flow Statement

Margins

Gross margin is 48.40%, with operating and profit margins of 4.11% and -2.74%.

Gross Margin	48.40%
Operating Margin	4.11%
Pretax Margin	1.18%
Profit Margin	-2.74%
EBITDA Margin	8.25%
EBIT Margin	4.11%
FCF Margin	13.11%

Dividends & Yields

Sam Chun Dang Pharm. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.20%
Shareholder Yield	-3.20%
Earnings Yield	-0.21%
FCF Yield	1.01%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sam Chun Dang Pharm. has an Altman Z-Score of 9.67.

Altman Z-Score	9.67
Piotroski F-Score	n/a